Please check your internet connection and try again.
# IV Hydrocortisone for Acute Asthma
## Overview
Intravenous (IV) hydrocortisone is a systemic corticosteroid used as an adjunct in the management of moderate-to-severe acute asthma exacerbations. It works by reducing airway inflammation, a key component of asthma pathophysiology.
## Primary Indications
Management of moderate-to-severe acute asthma exacerbations in patients who have not responded adequately to initial bronchodilator therapy.
## Adult Dosing
* 100 mg IV every 6 to 8 hours.
* Some protocols may recommend larger initial doses or more frequent administration in very severe cases. Dosing often transitions to oral corticosteroids once the patient can tolerate oral intake and shows clinical improvement.
## Pediatric Dosing
* **1 month to 12 years:** 1 mg/kg IV every 6 hours, not to exceed 100 mg per dose.
* **> 12 years:** Same as adult dosing: 100 mg IV every 6 to 8 hours.
## Dose Adjustments
* No specific dose adjustments are typically required for renal or hepatic impairment, but caution is advised due to potential accumulation and increased side effects.
## Contraindications
* Hypersensitivity to hydrocortisone or other corticosteroids.
* Systemic fungal infections.
* Live virus vaccination (in combination with immunosuppressive doses).
## Adverse Effects
Common adverse effects with short-term IV use are generally less frequent or severe than with long-term oral therapy but can include hyperglycemia, electrolyte imbalances (hypokalemia), increased susceptibility to infection, insomnia, mood changes, and fluid retention.
## Key Drug Interactions
* **CYP3A4 inducers (e.g., rifampin, phenytoin, carbamazepine):** May decrease hydrocortisone efficacy.
* **CYP3A4 inhibitors (e.g., ketoconazole, itraconazole):** May increase hydrocortisone levels.
* **Diuretics (potassium-depleting):** Increased risk of hypokalemia.
* **Diabetes medications:** May require increased doses due to hyperglycemia.
## Monitoring
* **Clinical response:** Respiratory rate, heart rate, oxygen saturation, work of breathing, wheezing.
* **Electrolytes:** Particularly potassium, especially with prolonged therapy or in predisposed individuals.
* **Blood glucose:** In patients with diabetes or at risk for hyperglycemia.
* **Signs of infection.**
## Clinical Pearls
* IV hydrocortisone typically takes several hours to exert its anti-inflammatory effect, and onset of action is slower than inhaled bronchodilators. It is therefore used adjunctively and does not replace inhaled or nebulized beta-agonists.
* Early administration is preferred in moderate-to-severe exacerbations.
* Transition to oral corticosteroids as soon as feasible, usually when the patient is stable and can tolerate oral intake.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and guidelines available, and consider individual patient factors when making treatment decisions.
